Topiramate Tablet, Film Coated
Product Images NDC 80425-0576

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Chemical structure diagram showing the molecular structure of topiramate, the active ingredient in the product. The diagram includes marked atoms and bonds representing the compound's composition and stereochemistry.*

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

A line graph showing cumulative rates for time to first seizure over a 500-day period comparing two topiramate dosages, 50 mg/day and 400 mg/day, each with sample sizes around 230. The graph illustrates seizure occurrence rates on the vertical axis and time in days on the horizontal axis, with a noted statistical significance (p = 0.0002).*

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

A bar graph showing the change from baseline to double-blind phase in average monthly migraine period rate with topiramate versus placebo. The x-axis lists placebo and three dosages of topiramate (50 mg/day, 100 mg/day, 200 mg/day) with corresponding participant numbers. The y-axis shows change rates with bars representing results from two separate studies, indicating greater reductions in migraine rates with increasing topiramate doses compared to placebo. Statistically significant differences are marked with asterisks.*

FDA Label Image

Topiramate 25mg #30 (Topiramate 25mg Tablet 80425 0576 01)

Label for topiramate 25 mg film-coated tablets, with a quantity of 30. The label includes the proprietary name Topamax for comparison, NDC 80425-0576-01, lot and expiration date fields, and the source labeler Unichem Pharmac. It shows storage instructions between 20° and 25°C and is intended for oral use. Labeler is Advanced Rx of Tennessee, LLC, located in Nashville, TN.*

FDA Label Image

Topiramate 25mg #60 (Topiramate 25mg Tablet 80425 0576 02)

Label for Topiramate 25 mg tablet, film coated, #60 count. The label notes comparison to Topamax and includes storage instructions (20° to 25°C). It features the labeler Advanced Rx of Tennessee, LLC, based in Nashville, TN, and displays barcodes and expiration date 12/31/2030.*

FDA Label Image

Topiramate 25mg #90 (Topiramate 25mg Tablet 80425 0576 03)

Label for topiramate 25 mg film-coated tablets, count 90, labeled by Advanced Rx of Tennessee, LLC. The label references a comparison to TOPAMAX, includes a National Drug Code (NDC 80425-0576-03), lot number placeholder, and expiration date of 12/31/2030. Storage instructions indicate a temperature range of 20° to 25°C (68° to 77°F). Barcodes and relevant serialization data are also present.*

FDA Label Image

Topiramate 25mg #270 (Topiramate 25mg Tablet 80425 0576 04)

Label for topiramate 25 mg film-coated tablets by Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0576-04, batch lot, expiration date 12/31/2030, storage instructions between 20°C and 25°C, comparison to Topamax, and barcodes. It states the medication is prescription only.*

FDA Label Image

Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.